How Much Money Does BioNTech make from vaccines?

BioNTech’s bet on mRNA is paying off. Its quarterly revenues grew from $30 million on 31 March 2020 to $2.467 billion on 31 March 2021.   Similarly, BioNTech’s Total Assets grew from $803 million on 31 March 2020 to $4.942 billion on 31 March 2021. In addition, the cash and short-term investments grew from $496 million on 31 March 2020 to $1.048 billion on 31 March 2021.   One person who believes in BioNTech (BNTX) is Mr. Market. Market paid $50.88 for BNTX on 26 May 2020 and $202.37 for the stock on 26 May 2021.

Continue ReadingHow Much Money Does BioNTech make from vaccines?

End of content

No more pages to load